DKTK Publications (PubMed)

Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy.

Authors: Debus C, Waltenberger M, Floca R, Afshar-Oromieh A, Bougatf N, Adeberg S, Heiland S, Bendszus M, Wick W, Rieken S, Haberkorn U, Debus J, Knoll M, Abdollahi A

Published: Oct 2019 / Journal: Sci Rep
see more details on PubMed

see more details on PubMed

Chemovirotherapy for pancreatic cancer: Gemcitabine plus oncolytic measles vaccine virus.

Authors: May V, Berchtold S, Berger A, Venturelli S, Burkard M, Leischner C, Malek NP, Lauer UM

Published: Oct 2019 / Journal: Oncol Lett
see more details on PubMed

see more details on PubMed

Dosimetric Impact of Interfractional Variations in Prostate Cancer Radiotherapy-Implications for Imaging Frequency and Treatment Adaptation.

Authors: Bostel T, Sachpazidis I, Splinter M, Bougatf N, Fechter T, Zamboglou C, Jäkel O, Huber PE, Baltas D, Debus J, Nicolay NH

Published: Oct 2019 / Journal: Front Oncol
see more details on PubMed

see more details on PubMed

Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy.

Authors: Zimmer P, Schmidt ME, Prentzell MT, Berdel B, Wiskemann J, Kellner KH, Debus J, Ulrich C, Opitz CA, Steindorf K

Published: Oct 2019 / Journal: Front Oncol
see more details on PubMed

see more details on PubMed

[Dose de-escalation during adjuvant chemoradiotherapy of HPV-associated oropharyngeal squamous cell carcinoma: the MC1273 phase II study].

Authors: Rühle A, Nicolay NH

Published: Oct 2019 / Journal: Strahlenther Onkol
see more details on PubMed

see more details on PubMed

Favorable prognosis in pediatric brainstem low-grade glioma - report from the German SIOP-LGG 2004 cohort.

Authors: Holzapfel J, Kandels D, Schmidt R, Pietsch T, Warmuth-Metz M, Bison B, Krauss J, Kortmann RD, Timmermann B, Thomale UW, Albert MH, Hernáiz Driever P, Witt O, Gnekow AK

Published: Oct 2019 / Journal: Int J Cancer
see more details on PubMed

see more details on PubMed

A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.

Authors: Shen J, Najafi S, Stäble S, Fabian J, Koeneke E, Kolbinger FR, Wrobel JK, Meder B, Distel M, Heimburg T, Sippl W, Jung M, Peterziel H, Kranz D, Boutros M, Westermann F, Witt O, Oehme I

Published: Oct 2019 / Journal: Cell Death Differ
see more details on PubMed

see more details on PubMed

FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109).

Authors: Modest DP, Martens UM, Riera-Knorrenschild J, Greeve J, Florschütz A, Wessendorf S, Ettrich T, Kanzler S, Nörenberg D, Ricke J, Seidensticker M, Held S, Buechner-Steudel P, Atzpodien J, Heinemann V, Seufferlein T, Tannapfel A, Reinacher-Schick AC, Geissler M

Published: Oct 2019 / Journal: J Clin Oncol
see more details on PubMed

see more details on PubMed

Development and validation of single field multi-ion particle therapy treatments.

Authors: Kopp B, Mein S, Dokic I, Harrabi S, Böhlen TT, Haberer T, Debus J, Abdollahi A, Mairani A

Published: Oct 2019 / Journal: Int J Radiat Oncol Biol Phys
see more details on PubMed

see more details on PubMed

We use cookies to make our website more user-friendly. Further information can be found in the data protection policy (privacy policy). To data protection policy

Ok